With lockdown measures, social distancing and strain on existing healthcare systems thanks to COVID-19, life sciences companies need a whole new model for reaching key stakeholders.
Why it matters
For life science brands, face-to-face (F2F) access to healthcare professionals has long been the backbone of marketing and sales strategy. With COVID-19 shutting this avenue of interaction down, there needs to be an overhaul of current engagement mod
Some LSCs are cutting marketing budgets in 2020 to manage profitability. In an MM&M survey, almost half of the 175 respondents said that they are already cutting 2020 promotional budgets, largely due to COVID19 and 74% respondents said that HCP engagement will be most impacted.